Cat. No. 6003
Chemical Name: 3-[[[(1R)-1-(4-Fluorophenyl)ethyl](
Biological ActivitySelective TRPM8 blocker (IC50 = 103 nM). Exhibits >100-fold selectivity for TRPM8 over a panel of receptors, ion channels and enzymes, including TRPV1 and TRPA1 ion channels. Reduces body temperature in rats and reverses cold-induced bladder capacity reduction in guinea pigs. Orally bioavailable.
Licensing InformationSold for research purposes under agreement from Pfizer Inc
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Andrews et al (2015) Discovery of a selective TRPM8 antagonist with clinical efficacy in cold-related pain. ACS Med.Chem.Lett. 6 419. PMID: 25893043 .
Winchester et al (2014) Inhibition of TRPM8 channels reduces pain in the cold pressor test in humans. J.Pharmacol.Exp.Ther. 351 259. PMID: 25125580.
If you know of a relevant reference for PF 05105679 please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses PF 05105679 from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: PF 05105679, supplier, PF05105679, selective, transient-receptor-potential, TRPM8, ion, channels, blocks, blockers, orally, bioavailable, Tocris Bioscience, TRPM Blocker products